GSK3B and melanoma: Similarly, Wang et al. demonstrated that SLFN5 suppresses melanoma cell migration and invasion by inhibiting MT1-MMP expression through AKT/GSK-3β/β-catenin signaling pathway (Wan et al., 2019).